Response to Letter; Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible, to Our Article; Axillary Adenopathy in Patients with Recent COVID-19 Vaccination : a New Diagnostic Dilemma
Shephard, Julie Lissidini, Germana Nicosia, Luca
Shephard, Julie
Lissidini, Germana
Nicosia, Luca
Citations
Altmetric:
Affiliation
Sandwell and West Birmingham NHS Trust; European Institute of Oncology
Other Contributors
Publication date
2022-05-31
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
No abstract available.
Citation
Ashoor A, Shephard J, Lissidini G, Nicosia L. Response to Letter; Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible, to Our Article; Axillary Adenopathy in Patients with Recent COVID-19 Vaccination: A New Diagnostic Dilemma. Korean J Radiol. 2022 Jul;23(7):775-776. doi: 10.3348/kjr.2022.0207. Epub 2022 May 31
Type
Correspondence